Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

GenAI making waves in medical device industry, says GlobalData

Generative artificial intelligence (GenAI) is impacting every industry and the medical device industry is no exception. From crunching massive data sets for R&D breakthroughs to mimicking human speech for improved patient care, the technology is making waves. GenAI is being implemented across the medical value chain for applications ranging from research & development, imaging & […]
Read more

FDA approval of Leqembi attracts mixed opinions from Twitter influencers, reveals GlobalData

Leqembi, the Alzheimer’s drug from Eisai and Biogen, has recently received the Food and Drug Administration’s (FDA) approval. Subsequently, Twitter influencer conversations around Leqembi witnessed a significant spurt, reveals the Social Media Analytics Platform of GlobalData, a leading data and analytics company. Shreyasee Majumder, Social Media Analyst at GlobalData, comments: “Influencers in the pharmaceutical business […]
Read more

GenAI has potential to address high cost, poor patient experience issues in pharma and healthcare, says GlobalData

The implementation of generative artificial intelligence (genAI) in pharma and healthcare has the potential to address the issues of high costs and poor patient experiences while enhancing efficiency and patient outcomes. With a growing focus on data-driven healthcare, genAI is poised to significantly transform the industry, says GlobalData, a leading data and analytics company. Kiran […]
Read more

Asia continues to dominate global refinery FCCU capacity additions by 2027, says GlobalData

Asia is expected to witness the highest refinery fluid catalytic cracking units (FCCU) capacity additions globally during 2023-2027, contributing approximately 58% of the total capacity additions by 2027, says GlobalData, a leading data and analytics company. GlobalData’s latest report, “Refinery Fluid Catalytic Cracking Units (FCCU) Capacity and Capital Expenditure (CapEx) Forecast by Region and Countries […]
Read more

NMPA approval for first BCMA CAR-T Therapy paves way for more multiple myeloma cell therapies, says GlobalData

Approval to dramatically change CAR-T therapies landscape GlobalData forecasts Fucaso sales to reach $69 million in 2029 Manufacturing and logistical challenges may impact commercial success Nanjing Iaso Biotherapeutics and Innovent Biologics have received China National Medical Product Administration (NMPA) approval for Fucaso (equecabtagene autoleucel) as a treatment for patients with relapsed or refractory multiple myeloma […]
Read more

Diagnosed incident cases of venous thromboembolism across 7MM set to reach 1.69 million in 2032, forecasts GlobalData

The burden of diagnosed incident cases of venous thromboembolism (VTE) in the 7MM* is expected to increase at an annual growth rate (AGR) of 1.50% from 1.47 million in 2022 to 1.69 million cases in 2032, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report, “Venous Thromboembolism: Epidemiology Forecast to 2032,” estimates that […]
Read more

Cryptocurrency market shows resilience, but faces challenges to gain mainstream acceptance, says GlobalData

The cryptocurrency industry, although volatile and speculative, has made significant progress in a short span of time, driven by remarkable innovation. In November 2021, the combined market value of all cryptocurrencies soared to a record-breaking $3 trillion. However, adverse macroeconomic circumstances and the collapse of major players, most notably FTX, caused a sharp 64% decline […]
Read more

Eli Lilly obesity drug retatrutide trials set to challenge weight loss results seen with other GLP-1RAs, says GlobalData

Eli Lilly’s retatrutide garnered interest recently following the release of results, which set a record for percentage body weight loss in the obesity space. Retatrutide, which is currently in development for obesity, type 2 diabetes (T2D), and non-alcoholic fatty liver disease (NAFLD), is of special interest due to addressing the need for improved efficacy within […]
Read more

Cultivated meat technology to disrupt $5.6 billion Malaysia meat and seafood markets, says GlobalData

The cultivated meat or lab-grown meat industry, which has gained a foothold in Singapore, is rapidly spreading its wings to neighboring Asian countries, including Malaysia. Cell AgriTech, a local food-tech startup, is at the forefront of the cultivated meat movement in Malaysia, in collaboration with Singapore-based Umami Meats. The company is commissioning a manufacturing plant […]
Read more
1 … 99 100 101 102 103 … 209